Medical Marijuana, Inc.
245 articles about Medical Marijuana, Inc.
-
Medical Marijuana, Inc. Reports $4.9 Million in Net Revenue in 2022 Third Quarter Financial and Operational Results
11/22/2022
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today its financial results for the quarter ending September 30, 2022, and provided an overview of recent operational highlights.
-
Medical Marijuana, Inc. Reports $7.8 Million in Net Revenue in 2022 First Quarter Financial and Operational Results
5/19/2022
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today its financial results for the quarter ending March 31, 2022, and provided an overview of recent operational highlights.
-
Medical Marijuana, Inc. Subsidiary Kannaway® Announces Positive Preliminary Results of Validcare CBD Safety Study
5/18/2022
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced today that its subsidiary Kannaway® has participated in the industry-led cannabidiol (CBD) Safety Study and that its preliminary results, released this week, are overwhelmingly positive for the safety profile of CBD.
-
Medical Marijuana, Inc. Subsidiary HempMeds® Co-CEO Caroline Heinz Featured in Yahoo! Finance
6/30/2020
Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that Caroline Heinz , co-CEO of its subsidiary HempMeds® , was featured in the major business pu
-
Medical Marijuana, Inc. Subsidiary HempMeds® Co-CEO Raul Elizalde Invited to Speak on Expert Panel About Cannabis in Mexico
6/23/2020
Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that Raul Elizalde, co-CEO of its subsidiary HempMeds®
-
Medical Marijuana, Inc. Subsidiary HempMeds® Appoints Vince DiMella as U.S. Director of Sales and Marketing
6/16/2020
Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® has hired Vince DiMella as its U.S. Director of Sales and Ma
-
Medical Marijuana, Inc. Subsidiary HempMeds® Co-CEOs Invited to Speak at The Global Cannabis Summit Virtual Conference
6/11/2020
Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that Raul Elizalde and Caroline Heinz , co-CEOs of its subsidiary HempMeds® , have been invi
-
Medical Marijuana, Inc. Investment Company Kannalife, Inc. Appoints Terrence O. Tormey to Board of Advisors
6/4/2020
Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its investment company Kannalife, Inc. ("Kannalife") (OTCQB: KLFE) has appointed biotech
-
Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Expands Research Division and Announces Dr. Sergei Svarovsky as Chief Scientific Officer of Subsidiary Sapphire Biotech
5/28/2020
Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its investment company AXIM® Biotechnologies, Inc. (OTCQB: AXIM) ("AXIM® Biotech" or "AXI
-
Medical Marijuana, Inc. Subsidiary Kannaway® Welcomes Leading Network Marketer Daniele Paiola Bellucci to the Company
5/22/2020
Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® has added leading network marketer Daniele Paiola Bellucci to
-
Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Files Patent for Unique Early Detection Cancer Biomarker
5/21/2020
Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that Sapphire Biotech, Inc.
-
Medical Marijuana, Inc. and Subsidiaries Kannaway® and HempMeds® Honored as Stevie® Award Winners in 2020 American Business Awards®
5/19/2020
Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Company and its subsidiaries received five prestigious Stevie® Awards in the 18th Annual American Business Awards®.
-
Medical Marijuana, Inc. Subsidiary Kannaway® Launches First-Ever CBD Fitness Program
5/11/2020
Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® has launched the first-ever cannabidiol (CBD) fitness program, Evolve.
-
Medical Marijuana, Inc. Reports 2019 Fourth Quarter and Year-End Financial and Operational Results: Net Revenue Surpasses $75 Million, Increasing 26% Year-Over-Year and Positive Adjusted EBITDA
4/29/2020
Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today financial results for the quarter and year ending Dec. 31, 2019 , and provided an overview of
-
Medical Marijuana, Inc. Subsidiary Kannaway® Promotes Janne Heimonen to Company's Managing Director of International
4/22/2020
Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® has promoted Janne Heimonen to Managing Director of International.
-
Blake Schroeder, CEO of Medical Marijuana, Inc. Subsidiary Kannaway®, Honored as Top CEO of the Year by the International Association of Top Professionals
4/16/2020
Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that Blake Schroeder, CEO of the Company's subsidiary Kannaway®, was honored as the Top CEO of the Year by the International Association of Top Professionals (IAOTP).
-
Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Receives Notice of Allowance from USPTO for Trademark of Atopidine™
4/9/2020
Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its investment company Kannalife, Inc. ("Kannalife") (OTCQB: KLFE),
-
Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Receives New U.S. Patent Issuance for Chewing Gum Comprising Cannabinoids and Nicotine
4/8/2020
Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its investment company AXIM® Biotechnologies, Inc
-
Medical Marijuana, Inc. CEO Featured in U.S. News and World Report Providing Insight on Penny Stocks
4/2/2020
Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), the first-ever publicly traded cannabis company in the United States that launched the world's first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Company's CEO Dr. Stuart Titus was featured in global financial news outlet U.S. News and World Report discussing his expertise in penny stocks.
-
Medical Marijuana, Inc. CEO Featured in Reuters Coverage Highlighting the Impact of COVID-19 on Cannabis Industry
3/26/2020
Medical Marijuana, Inc. (OTC: MJNA) (the "Company"), announced today that the Company's CEO Dr. Stuart Titus was featured in global financial news outlet Reuters discussing the impact of COVID-19 on the cannabis industry.